Records containing: Ovarian Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-28Phase I, Two-Part, Multi-Center, First-in-Human Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors
-
CLINICAL_TRIALS study record update · 2024-03-15Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI (Risk of Malignancy Index) and Tumor Markers Such as CA125 (Cancer Antigen 125) and HE4 (Human Epididymal Protein 4)
-
CLINICAL_TRIALS study record update · 2023-10-27Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice
-
CLINICAL_TRIALS study record update · 2020-03-26European Multicenter Validation of an ADNEXMR SCORING System for Characterizing Adnexal Masses: EURAD-MR Classification
-
CLINICAL_TRIALS study record update · 2020-01-14Real-Time Identification of Lesions and Nerves by Using Indocyanine Green Fluorescent Imaging in Gynecological Surgery
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-12-17Clinical Study of Chimeric CD(Cluster of Differentiation)133 Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Malignancies
-
CLINICAL_TRIALS study record update · 2017-07-26European Multicenter Validation of an ADNEXMR SCORING System for Characterizing Adnexal Masses: "EURAD-MR Classification"
-
CLINICAL_TRIALS study record update · 2015-10-20Clinical Study of Chimeric Mesothelin Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Malignancies
-
CLINICAL_TRIALS study record update · 2015-01-15A Phase 1, Single-blind, Randomized, Two-way, Crossover Bioequivalence Study of Intravenously Administered ATI 0918 in Patients With Ovarian Cancer That Has Progressed or Recurred After Platinum-based Chemotherapy
-
CLINICAL_TRIALS study record update · 2008-04-30Whole Blood Collection Protocol For Ovarian Assay Clinical Trial In Women With Ovarian Tumors
-
CLINICAL_TRIALS study record update · 2007-11-22Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses